PreveCeutical Medical Inc (CNSX:PREV – Get Free Report) insider Michael Moeller acquired 650,000 shares of PreveCeutical Medical stock in a transaction dated Friday, March 14th. The shares were bought at an average cost of $0.03 per share, with a total value of $16,250.00.
PreveCeutical Medical Stock Performance
PreveCeutical Medical Company Profile
PreveCeutical Medical Inc, a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; BSV Peptide Program for targeting cancer progression; Non-Addictive Analgesic for pain management; and Dual Gene Therapy for type 2 diabetes and obesity.
Featured Stories
- Five stocks we like better than PreveCeutical Medical
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- What is the MACD Indicator and How to Use it in Your Trading
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- The How And Why of Investing in Oil Stocks
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for PreveCeutical Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PreveCeutical Medical and related companies with MarketBeat.com's FREE daily email newsletter.
